Using aseptic technique, 0.8 mL of E75 acetate solution (1136 mcg E75 peptide) is added to the re-constituted Leukine. Taking into account vial losses, this procedure will yield a total dose of approximately 1010 mcg of E75 peptide in a volume of 1.6 mL. Stability: Once prepared, administer the E75 peptide/placebo and lyophilized Leukine mixture within 6 hours. Materials: 1.